Investing.com – AbbVie (NYSE:) reported on Friday third quarter that beat analysts’ forecasts and revenue that topped expectations.
AbbVie announced earnings per share of $2.83 on revenue of $12.88B. Analysts polled by Investing.com anticipated EPS of $2.76 on revenue of $12.71B.
AbbVie shares are down 8% from the beginning of the year, still down 20.35% from its 52 week high of $101.28 set on July 17. They are under-performing the which is up 2.46% from the start of the year.
AbbVie shares gained 0.35% in pre-market trade following the report.
AbbVie follows other major Healthcare sector earnings this month
AbbVie’s report follows an earnings beat by J&J on October 13, who reported EPS of $2.2 on revenue of $21.08B, compared to forecasts EPS of $1.98 on revenue of $20.2B.
Pfizer had beat expectations on Tuesday with third quarter EPS of $0.72 on revenue of $12.13B, compared to forecast for EPS of $0.69 on revenue of $12.31B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.